Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson.
FDA questions data for J&J ovarian cancer drugCourtesy Newsvine - business Mon, 07/13/2009 - 08:20
Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson. Related itemsWhat's in a cigarette? FDA to study ingredients
Wyeth sues FDA to block rival generic antibiotic
FDA approves new HIV test from Abbott Laboratories
AT&T 5800 Accessory Handset for 5800 Series Phones
Iris USOA447 IRIScan Express 2 Portable Scanner
|
Popular by tags WeekMonth |
Post new comment